Free Trial

BIOLASE (BIOL) SEC Filings & 10K Form

BIOLASE logo
$0.0050 0.00 (0.00%)
(As of 11/15/2024 ET)

Recent BIOLASE SEC Filings

DateFilerForm TypeView
11/14/2024
6:20 PM
BIOLASE (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
4:38 PM
Anson Funds Management LP (Filed by)
BIOLASE (Subject)
Form SC 13G/A
11/07/2024
3:51 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/08/2024
3:47 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
6:39 AM
BIOLASE (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/28/2024
3:05 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:30 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
5:06 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:17 PM
BIOLASE (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/17/2024
5:42 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:21 PM
BIOLASE (Filer)
Form 424B4
04/22/2024
11:15 PM
BIOLASE (Filer)
Form EFFECT
04/19/2024
4:07 PM
BIOLASE (Filer)
Form POS AM
04/19/2024
3:13 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:55 PM
BIOLASE (Filer)
Form POS AM
04/02/2024
11:15 PM
BIOLASE (Filer)
Form EFFECT
03/27/2024
3:43 PM
BIOLASE (Filer)
Form S-1/A
03/08/2024
5:31 AM
BIOLASE (Filer)
Form PRE 14A
03/05/2024
5:05 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
3:39 PM
BIOLASE (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G
02/21/2024
6:01 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:21 PM
BIOLASE (Filer)
Form 424B1
02/14/2024
12:10 PM
BIOLASE (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
02/13/2024
7:03 PM
BIOLASE (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
02/09/2024
7:44 AM
BIOLASE (Filer)
Form S-1/A
02/07/2024
5:04 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
5:11 AM
BIOLASE (Filer)
Form S-1/A
01/30/2024
8:57 PM
BIOLASE (Filer)
Form S-1/A
01/24/2024
4:21 PM
BIOLASE (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/19/2024
5:09 AM
BIOLASE (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/26/2023
4:22 PM
BIOLASE (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/20/2023
1:13 PM
BIOLASE (Filer)
Form D
Notice of Exempt Offering of Securities 
12/08/2023
8:23 AM
BIOLASE (Filer)
Form 424B5
12/08/2023
8:25 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIOL) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners